Olema Pharmaceuticals Statistics
Total Valuation
OLMA has a market cap or net worth of $334.15 million. The enterprise value is -$98.51 million.
Important Dates
The next estimated earnings date is Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OLMA has 68.33 million shares outstanding. The number of shares has increased by 29.83% in one year.
| Current Share Class | 68.33M |
| Shares Outstanding | 68.33M |
| Shares Change (YoY) | +29.83% |
| Shares Change (QoQ) | +14.90% |
| Owned by Insiders (%) | 4.59% |
| Owned by Institutions (%) | 70.97% |
| Float | 41.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.89 |
| P/TBV Ratio | 0.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.50, with a Debt / Equity ratio of 0.00.
| Current Ratio | 10.50 |
| Quick Ratio | 10.45 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -39.07% and return on invested capital (ROIC) is -26.67%.
| Return on Equity (ROE) | -39.07% |
| Return on Assets (ROA) | -24.43% |
| Return on Invested Capital (ROIC) | -26.67% |
| Return on Capital Employed (ROCE) | -34.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.35M |
| Employee Count | 96 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.85% in the last 52 weeks. The beta is 2.11, so OLMA's price volatility has been higher than the market average.
| Beta (5Y) | 2.11 |
| 52-Week Price Change | -50.85% |
| 50-Day Moving Average | 4.28 |
| 200-Day Moving Average | 8.79 |
| Relative Strength Index (RSI) | 64.51 |
| Average Volume (20 Days) | 1,093,246 |
Short Selling Information
The latest short interest is 6.08 million, so 8.90% of the outstanding shares have been sold short.
| Short Interest | 6.08M |
| Short Previous Month | 6.50M |
| Short % of Shares Out | 8.90% |
| Short % of Float | 14.80% |
| Short Ratio (days to cover) | 5.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -142.26M |
| Pretax Income | -109.63M |
| Net Income | -129.47M |
| EBITDA | -141.87M |
| EBIT | -142.26M |
| Earnings Per Share (EPS) | -$2.20 |
Full Income StatementBalance Sheet
The company has $434.09 million in cash and $1.43 million in debt, giving a net cash position of $432.66 million or $6.33 per share.
| Cash & Cash Equivalents | 434.09M |
| Total Debt | 1.43M |
| Net Cash | 432.66M |
| Net Cash Per Share | $6.33 |
| Equity (Book Value) | 408.96M |
| Book Value Per Share | 5.50 |
| Working Capital | 396.72M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$104.35 million and capital expenditures -$159,000, giving a free cash flow of -$104.51 million.
| Operating Cash Flow | -104.35M |
| Capital Expenditures | -159,000 |
| Free Cash Flow | -104.51M |
| FCF Per Share | -$1.53 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |